|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:D228875 |
| 產(chǎn)品名稱:N-demethyl Pazopanib (Positional Isomer) |
| 產(chǎn)品CAS:1797832-43-9 |
| 規(guī)格含量:10mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
D228875 |
| 名稱: |
N-demethyl Pazopanib (Positional Isomer) |
| 別名: |
5-[[2-[(2,3-Dimethyl-2H-indazol-6-yl)amino]-4-pyrimidinyl]amino]-2-methyl-benzenesulfonamide |
| CAS號: |
1797832-43-9 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
423.49 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
N-demethyl Pazopanib is a Pazopanib (P210925) impurity. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
| 參考文獻 |
|
|
|
|